Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II olaparib study in advanced BRCA-associated breast cancer
2006-006458-91Phase 2Completed
- Sponsor
- KuDOS Pharmaceuticals
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of olaparib in breast cancer (2 arms), sponsored by KuDOS Pharmaceuticals. Primary endpoint: Objective tumour response rate. Started Apr 2007; status: completed.
02
Drugs
olaparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-006458-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006458-91.